Home

T. Rowe Price Investment Management reported a 6.7% stake in Kymera Therapeutics KYMR · 5,460,257 sh · passive holder

Trade details

Type
5% stake report
Report
13G passive
Stake
6.7%
Last report
First report
Shares held
5,460,257 sh
Class
COMMON STOCK
Event date
26/03/31
Filed
26/05/15

First 5%+ report · 6.7% stake

Kymera Therapeutics trades, last 26 weeks

What else happened in Kymera Therapeutics around then

Filed or reported within 30 days of the trade day · 03/01~04/30

T. Rowe Price Investment Management's other 5% stake reports